- Products
Tesamorelin
The Only FDA-Approved GHRH Peptide for Visceral Fat and Metabolic Wellness
If you’ve been researching Peptides for stubborn belly fat, metabolic decline, or longevity, Tesamorelin keeps coming up for a reason. It’s the only FDA-approved GHRH (growth hormone-releasing hormone) peptide in existence, and unlike most things in the peptide space, it has real randomized controlled trial data behind it. This page covers what Tesamorelin is, what the clinical evidence actually shows, who it’s appropriate for, and what working with Breakthru Rx looks like from day one.
- Product Details
Tesamorelin Product Overview
Tesamorelin Formula
Tesamorelin is a synthetic GHRH analog that stimulates your pituitary gland to release your own growth hormone in its natural rhythm, not synthetic HGH introduced from outside.
It’s sold as Egrifta, available in two formulations: Egrifta SV (daily reconstitution) and Egrifta WR (weekly reconstitution), approved by the FDA in March 2025. FDA approval covers excess abdominal visceral fat in HIV-related lipodystrophy, first granted in 2010, making it one of the most clinically validated peptides available. Off-label use for visceral fat, metabolic syndrome, and age-related GH decline is legally permissible at a physician’s discretion.
At Breakthru Rx, every patient goes through a full clinical evaluation before we discuss any protocol.
Key Ingredients
Tesamorelin does one thing that distinguishes it from every other peptide in this category it works with your body’s own hormone system instead of bypassing it.
- Pituitary Stimulation: Tesamorelin binds to GHRH receptors in the pituitary gland and triggers the release of your own growth hormone in natural pulses. This preserves the body’s feedback loop, which is a critical distinction from exogenous HGH therapy, where the feedback system gets suppressed.
- IGF-1 Elevation: The GH release from your pituitary raises IGF-1 (insulin-like growth factor-1), a downstream hormone involved in cellular repair, fat metabolism, muscle density, and cognitive function.
- Visceral Fat Targeting: Tesamorelin selectively reduces visceral adipose tissue, the deep abdominal fat wrapped around organs, without significantly affecting subcutaneous fat. This specificity is what makes it clinically meaningful. Visceral fat is directly tied to cardiovascular disease risk, insulin resistance, and metabolic dysfunction.
At Breakthru Rx, dosing starts at 2mg subcutaneously once daily, injected in the abdominal area, and your provider monitors IGF-1 levels throughout to ensure response stays within the physiological range.
Benefits
Tesamorelin has one of the most documented clinical profiles of any peptide currently used in metabolic and longevity medicine:
- Visceral Fat Reduction: In the pivotal Phase III trials published in the NEJM (2010), Tesamorelin reduced visceral adipose tissue by approximately 15–18% over 26 weeks compared to placebo roughly 17.8 cm² mean reduction in the treatment group vs 0.5 cm² in placebo. These effects were maintained at 52 weeks with continued treatment. Subcutaneous fat was not significantly affected; the reduction is specific to the dangerous visceral fat.
- Improved Lipid Profiles: Trial data confirmed significant reductions in triglycerides and total cholesterol in treated patients.
- Muscle Mass and Density: A 2018 analysis of two RCTs confirmed Tesamorelin increased both skeletal muscle area and density.
- Cognitive Support: A 2012 controlled trial involving 152 adults showed Tesamorelin improved executive function and verbal memory in both healthy older adults and those with mild cognitive impairment over 20 weeks. A 2025 paper confirmed reduced cardiovascular risk markers in HIV patients through the visceral fat reduction pathway.
- Sleep and Energy:The largest natural GH pulse occurs during deep sleep. Tesamorelin amplifies this pulse, and consistent improvements in sleep quality are among the first effects most patients notice.
These are real trial results, not forum anecdotes. At Breakthru Rx, we tell you what the data actually supports and where the evidence is still thin.
Daily Usage
Tesamorelin is administered as a once-daily subcutaneous injection in the abdomen. At Breakthru Rx, your provider sets your protocol we don’t publish a generic dosing guide here because the right approach depends on your clinical situation.
- Standard Dosing: 2 mg once daily for the Egrifta SV formulation. Egrifta WR (the newer F8 formulation approved March 2025) uses 1.28mg daily but requires reconstitution only once per week, which is simpler for most patients.
- Timing: Best administered in the evening to align with the body’s natural nocturnal GH pulse. Fasting before injection is recommended when possible.
- Monitoring: IGF-1 levels are checked periodically throughout treatment. If IGF-1 rises above the upper limit for your age, your provider adjusts the dose or pauses treatment. This is not optional it is part of how we keep therapy safe and effective.
- Duration: Most clinical protocols run 8 to 26 weeks. Benefits begin showing on imaging and labs around the 8 to 12 week mark. Your Breakthru Rx provider reviews the response and discusses continuation based on your actual results.
Features
What separates Tesamorelin from other peptides, and what you get at Breakthru Rx:
- Only FDA-approved GHRH peptide. Nothing else in this class has the same level of clinical validation for visceral fat reduction. That regulatory status matters.
- Targets visceral fat specifically, not generalized weight loss. Tesamorelin goes after the metabolically dangerous fat wrapped around organs, the kind tied to cardiovascular risk, insulin resistance, and inflammation.
- Preserves natural hormone rhythm. By stimulating your pituitary rather than replacing GH externally, Tesamorelin keeps your feedback system intact. That’s a meaningful safety advantage over exogenous HGH therapy.
- Licensed provider oversight at Breakthru Rx from day one: IGF-1 monitoring, dose management, and clinical follow-up are built into every plan. You don’t get that from an online vial purchase.
- In-person and virtual consultations. Serving Denver, Parker, Aurora, Centennial, Lone Tree, Castle Rock, and Highlands Ranch.
Quality
Tesamorelin is a peptide, and peptide quality varies enormously depending on the source. Purity, potency, and proper cold-chain handling from production through delivery all affect both safety and outcome.
At Breakthru Rx, we work only with sources that provide third-party laboratory testing for potency and purity, batch-level documentation, screening for heavy metals and microbial contaminants, and a certificate of analysis available on request.
Tesamorelin must be stored refrigerated and handled properly after reconstitution. This is not a peptide you want sourced from an unverified online seller. Ask us about our sourcing we share the documentation without hesitation.
Manufacturing Process
Brand-name Tesamorelin (Egrifta SV and Egrifta WR) is manufactured by Theratechnologies under FDA Good Manufacturing Practice standards. The peptide is produced through solid-phase peptide synthesis, with a trans-3-hexenoic acid modification at the N-terminal that protects it from rapid breakdown by the enzyme DPP-4, giving it a longer effective half-life than natural GHRH.
Egrifta WR, approved in March 2025, uses a new F8 formulation that allows weekly reconstitution while maintaining the same once-daily injection schedule. This significantly reduces the preparation burden for patients on longer protocols.
At Breakthru Rx, we work only with sources that can document manufacturing practices, cold-chain compliance, and batch consistency from production through delivery.
Our products come from 503A compliant facilities.
How It Works in the Body
After subcutaneous injection, Tesamorelin is absorbed into the bloodstream and travels to the pituitary gland, where it binds to GHRH receptors and triggers GH release in natural pulses, the same pattern your body uses on its own.
- Pituitary → GH Release: Pulsatile growth hormone release is stimulated, mimicking the body’s natural nocturnal GH secretion pattern.
- GH → IGF-1: Elevated GH triggers the liver to produce more IGF-1, which circulates systemically and activates downstream effects on fat metabolism, muscle tissue, cellular repair, and cognitive function.
- IGF-1 → Visceral Fat Mobilization: IGF-1 acts on visceral adipose tissue, promoting lipolysis the breakdown of stored fat selectively in the deep abdominal region.
Most Breakthru Rx patients begin noticing changes in energy, sleep, and appetite regulation within the first 4 to 6 weeks. Measurable reductions in visceral fat typically appear on imaging and lab markers at the 8- to 12-week mark with consistent, supervised use. Monitoring is how we track whether it’s working for you and adjust if it isn’t.
Tesamorelin Benefits
- Physician led care at every stage
- Tailored dosing with IGF-1 monitoring throughout
- Ongoing support beyond the first visit
- Only FDA approved GHRH peptide real Phase III trial data
- Accessible care across Colorado's Front Range
Tesamorelin Considerations
- Off label use requires physician evaluation
- Contraindicated in active malignancy angiogenesis concern
- Banned year round by WADA not for athletes
- Side effects: injection reactions, joint pain, mild edema
- Periodic IGF-1 monitoring required provider adjusts dose
Need More Info?
- Testimonials
TRUSTED BY PATIENTS
- Service Areas
Areas We Serve
Frequently Asked Questions
Have Any Question? Here are some questions that most people ask us!
Does Breakthru Rx offer Tesamorelin therapy in Colorado?
Yes, at Breakthru Rx, we offer Tesamorelin through a fully provider-led consultation process, not a click-and-order experience. You work directly with a licensed clinician who reviews your health history, monitors your IGF-1 levels throughout, and builds a protocol around your specific situation.
Is Tesamorelin from Breakthru Rx compounded or brand-name?
We work through compliant, verified channels only and are transparent about what that means for your options. Brand-name Egrifta (SV or WR) is available as an FDA-approved prescription. Your Breakthru Rx provider will walk you through which formulation makes the most clinical and practical sense for you before any decision is made.
How do I get Tesamorelin from Breakthru Rx if I live in Parker?
Book a free consultation virtual or in-person and we’ll take it from there. Breakthru Rx serves Parker, Castle Rock, Highlands Ranch, Centennial, Lone Tree, Aurora, and the greater Denver metro with the same licensed provider and same standard of care wherever you are.
Why choose Breakthru Rx for Tesamorelin in Colorado?
How much does a Tesamorelin consultation at Breakthru Rx cost?
Does Breakthru Rx offer a Tesamorelin / Ipamorelin combination
Yes for patients who want more comprehensive growth hormone support alongside visceral fat reduction, Breakthru Rx offers a combined Tesamorelin / Ipamorelin protocol. Your provider will assess whether this combination or Tesamorelin alone is the right approach for your specific goals during your evaluation.
Ready to Have a Conversation About Your Health Goals?
Whether you’re focused on visceral fat, metabolic health, longevity, cognitive support, or just wanting to feel like yourself again, it starts with a real conversation. No pressure. No assumptions. Just an honest discussion about what’s going on and what might actually help you.
Working with patients across Colorado, Breakthru Rx builds personalized, medically guided approaches to long-term wellness. When you’re ready, we’re here.
